 |
|
Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
Sara Battistella, Francesca D’Arcangelo, Marco Grasso, Alberto Zanetto, Martina Gambato, Giacomo Germani, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra
Clin Mol Hepatol. 2023;29(Suppl):S286-S301. Published online 2022 Dec 28 DOI: https://doi.org/10.3350/cmh.2022.0392
|
|
Citations to this article as recorded by
 Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019
Jacob Romano, Jessica Burnside, Giada Sebastiani, Alnoor Ramji, Keyur Patel, Mark Swain, Sahar Saeed
Annals of Hepatology.2025; 30(1): 101757. CrossRef Macronutrient Modulation in Metabolic Dysfunction-Associated Steatotic Liver Disease—the Molecular Role of Fatty Acids compared with Sugars in Human Metabolism and Disease Progression
Sinéad M Mullin, Aidan J Kelly, Méabh B Ní Chathail, Suzanne Norris, Christopher E Shannon, Helen M Roche
Advances in Nutrition.2025; 16(3): 100375. CrossRef Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk
Vlad Alexandru Ionescu, Gina Gheorghe, Nicolae Bacalbasa, Camelia Cristina Diaconu
Biomolecules.2025; 15(2): 163. CrossRef Metabolic dysfunction-associated steatotic liver disease correlates with higher lower graft survival in liver transplant recipients with hepatocellular carcinoma
Marwan Alsaqa, Leandro Sierra, Ana Marenco-Flores, Ximena Parraga, Romelia Barba, Daniela Goyes, N. Begum Ozturk, Michael P. Curry, Alan Bonder, Behnam Saberi
European Journal of Gastroenterology & Hepatology.2025; 37(4): 497. CrossRef Clinical and Economic Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Spanish Mediterranean Region: A Population-Based Study
Javier Díaz Carnicero, Inma Saurí-Ferrer, Josep Redon, Jorge Navarro, Gonzalo Fernández, Carlos Hurtado, Karine Ferreira, Carolina Alvarez-Ortega, Antón Gómez, Carlos J. Martos-Rodríguez, David Martí-Aguado, Desamparados Escudero, Marta Cedenilla
Journal of Clinical Medicine.2025; 14(7): 2441. CrossRef MASLD or MAFLD: fatty liver by any name will pose the same challenge
Anil Chandra Anand, Dibyalochan Praharaj
Metabolism and Target Organ Damage.2025;[Epub] CrossRef Cardiac Remodeling and Arrhythmic Burden in Pre-Transplant Cirrhotic Patients: Pathophysiological Mechanisms and Management Strategies
Charilila-Loukia Ververeli, Yannis Dimitroglou, Stergios Soulaidopoulos, Evangelos Cholongitas, Constantina Aggeli, Konstantinos Tsioufis, Dimitris Tousoulis
Biomedicines.2025; 13(4): 812. CrossRef Correspondence to letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
Soon Kyu Lee, Jong Young Choi
Clinical and Molecular Hepatology.2025; 31(2): e212. CrossRef Risk Factors Related to the Development of Nonalcoholic Fatty Liver: A Systematic Review
Omaira Valencia, Carolina López, Esteban Vanegas-Duarte, Carolina Fillizola, Diana Fernanda Bejarano Ramírez, Nicolás Andrés Cortés Mejía, Alonso Vera Torres, Kevork M. Peltekian
Canadian Journal of Gastroenterology and Hepatology.2025;[Epub] CrossRef Safety, efficacy, and outcomes of invasive coronary angiography in liver transplant candidates
Carme Ginard, Giulia Pagano, Salvatore Brugaletta, Annabel Blasi, Marta Sánchez-Ric, Ander Regueiro, Roger Pujol, Sergio Rodriguez-Tajes, Pablo Ruiz, Jordi Colmenero, Gonzalo Crespo
JHEP Reports.2025; 7(7): 101428. CrossRef The Relationships Between MASLD, Extrahepatic Multimorbidity, and All-Cause Mortality in the UK Biobank Cohort
Qi Feng, Chioma N Izzi-Engbeaya, Andrea D Branch, Benjamin H Mullish, Pinelopi Manousou, Mark Woodward
The Journal of Clinical Endocrinology & Metabolism.2025;[Epub] CrossRef MAFLD as a Cardiovascular Risk Factor: An Extended Retrospective Study with a Control Group
Małgorzata Szymala-Pędzik, Marcin Piersiak, Maciej Pachana, Karolina Lindner-Pawłowicz, Wioletta Szczepaniak, Małgorzata Sobieszczańska
Journal of Clinical Medicine.2025; 14(12): 4181. CrossRef Metabolic-associated fatty liver disease: Noninvasive diagnosis and assessment of liver fibrosis
O. O. Karshina, I. S. Sabirov
Meditsinskiy sovet = Medical Council.2025; (8): 72. CrossRef How best to combine liver transplantation and bariatric surgery?—Results from a global, web‐based survey
Jeannette Widmer, Janina Eden, Fariba Abbassi, Roberta Angelico, Fabian Rössler, Beat Müllhaupt, Philipp Dutkowski, Marco Bueter, Andrea Schlegel
Liver International.2024; 44(2): 566. CrossRef Exploring the effects of epigallocatechin gallate on lipid metabolism in the rat steatotic liver during normothermic machine perfusion: Insights from lipidomics and RNA sequencing
Shuxuan Li, Yao Zhi, Wentao Mu, Mingqian Li, Guoyue Lv
European Journal of Pharmacology.2024; 964: 176300. CrossRef Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond
Allison Soto, Colby Spongberg, Alessandro Martinino, Francesco Giovinazzo
Biomedicines.2024; 12(2): 397. CrossRef Metabolic dysfunction-associated steatotic liver disease: A silent pandemic
Arghya Samanta, Moinak Sen Sarma
World Journal of Hepatology.2024; 16(4): 511. CrossRef Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patients
David Pérez Compte, Lucas Etourneau, Anne-Marie Hesse, Alexandra Kraut, Justine Barthelon, Nathalie Sturm, Hélène Borges, Salomé Biennier, Marie Courçon, Marc de Saint Loup, Victoria Mignot, Charlotte Costentin, Thomas Burger, Yohann Couté, Christophe Bru
Biomarker Research.2024;[Epub] CrossRef Cardiac abnormalities pre- and post-liver transplantation for metabolic dysfunction-associated steatohepatitis – Evidence and special considerations
Steven M. Elzein, Elizabeth W. Brombosz, Sudha Kodali
Journal of Liver Transplantation.2024; 15: 100228. CrossRef Serum Creatinine as an Independent Predictor of Moderate to Severe Fibrosis in Chinese American Non-obese Metabolic Dysfunction-Associated Steatotic Liver Disease
Michael Sun, Vincent J Yao, Aivi A Rahman, Kevin Liu, Saud Rehman, Amber Sun, Alan C Yao
Cureus.2024;[Epub] CrossRef Recent trends and new developments in liver transplantation
Yasuhiko Sugawara, Taizo Hibi
BioScience Trends.2024; 18(3): 206. CrossRef Cenicriviroc Suppresses and Reverses Steatohepatitis by Regulating Macrophage Infiltration and M2 Polarization in Mice
Guanliang Chen, Yanwen Yu, Yuqin Zhu, Mayumi Nagashimada, Yajiao Wang, Naoto Nagata, Liang Xu
Endocrinology.2024;[Epub] CrossRef Metabolic bariatric surgery, alcohol misuse and liver cirrhosis: a narrative review
Matthew L. Basa, Danielle S. Cha, David P. Mitchell, Daniel L. Chan
Metabolism and Target Organ Damage.2024;[Epub] CrossRef The interrelation of cardiometabolic risk factors and metabolic dysfunction-associated steatotic liver disease subtypes
A. Yu. Ishchenko, M. Yu. Galushko, I. G. Bakulin
Meditsinskiy sovet = Medical Council.2024; (15): 146. CrossRef Cardio-metabolic disorders in a patient with non-alcoholic fatty liver disease and normal body weight
Svetlana V. Turkina, Mikhail E. Statsenko, Irina A. Tyshchenko, Marina N. Titarenko, Marina A. Kosivtsova, Elena E. Gorbacheva
Journal of Volgograd State Medical University.2024; 21(3): 109. CrossRef Exploring the knowledge and attitudes towards metabolic dysfunction associated fatty liver disease (MAFLD): Validation and correlations of MAFLD-knowledge questionnaire and MAFLD-attitude questionnaire
Samah Al Tawil, Mohamad Abdelkhalik, Adam El Fouani, Nour Allakiss, Lama Mattar, Wissam H. Faour, Rajaa Chatila
Heliyon.2024; 10(22): e40217. CrossRef Weight Loss After Sleeve Gastrectomy According to Metabolic Dysfunction-Associated Steatotic Liver Disease Stage in Patients with Obesity: A Liver Biopsy-Based Prospective Study
José Ignacio Martínez-Montoro, Isabel Arranz-Salas, Carolina Gutiérrez-Repiso, Ana Sánchez-García, Luis Ocaña-Wilhelmi, José M. Pinazo-Bandera, Diego Fernández-García, Araceli Muñoz-Garach, Dieter Morales-García, Miren García-Cortés, Eduardo García-Fuente
Nutrients.2024; 16(22): 3857. CrossRef Liver transplantation for alcohol-related liver disease in Korea: The need for patient management guidelines
Soon Kyu Lee
Annals of Liver Transplantation.2024; 4(2): 40. CrossRef Post-transplant complications in alcohol- and metabolic-associated steatotic liver disease
Shekhar Singh Jadaun, Sanjiv Saigal
Metabolism and Target Organ Damage.2024;[Epub] CrossRef How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
Byeong Geun Song, Dong Hyun Sinn
Clinical and Molecular Hepatology.2023; 29(2): 411. CrossRef Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies
Qingfu Dong, Haolin Bao, Jiangang Wang, Wujiang Shi, Xinlei Zou, Jialin Sheng, Jianjun Gao, Canghai Guan, Haoming Xia, Jinglin Li, Pengcheng Kang, Yi Xu, Yunfu Cui, Xiangyu Zhong
Frontiers in Medicine.2023;[Epub] CrossRef Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients
Simone Di Cola, Giulia Cusi, Lucia Lapenna, Jakub Gazda, Stefano Fonte, Marco Mattana, Gianluca Mennini, Patrizio Pasqualetti, Manuela Merli, Xingshun Qi
Canadian Journal of Gastroenterology and Hepatology.2023; 2023: 1. CrossRef Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases
Silvia Espina, Diego Casas-Deza, Vanesa Bernal-Monterde, María José Domper-Arnal, Sandra García-Mateo, Alberto Lué
Nutrients.2023; 15(15): 3487. CrossRef New Developments and Challenges in Liver Transplantation
Amjad Khalil, Alberto Quaglia, Pierre Gélat, Nader Saffari, Hassan Rashidi, Brian Davidson
Journal of Clinical Medicine.2023; 12(17): 5586. CrossRef Outcomes in elderly patients undergoing hepatic resection compared to liver transplant for hepatocellular carcinoma
Sameer A. Khan, Fasih A. Ahmed, Muhammad S. Hafeez, Lawrence R. Feng, Abhinav Seth, Yong K. Kwon, Hassan Aziz
Journal of Surgical Oncology.2023; 128(8): 1320. CrossRef
|